Leukemia Acute Myeloid - AML

7 clinical trials · Condition

Record	Firm	Date
Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma (NCT07518654)	Michel Duval	2026-05-01
Study With Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid Leukemia (NCT07392814)	Nantes University Hospital	2026-03-10
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia (NCT06944119)	Tel-Aviv Sourasky Medical Center	2025-01-20
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML (NCT05586074)	Sunshine Lake Pharma Co., Ltd.	2023-03-03
Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies (NCT06886425)	Assistance Publique Hopitaux De Marseille	2021-06-14
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation (NCT02421939)	Astellas Pharma Global Development, Inc.	2015-10-20
Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT (NCT01810120)	Mariella Enoc	2012-01-01

Every clearance here is in the API, with alerts when new ones post.